Acadia Healthcare Company, Inc. (ACHC) P/E Ratio History
Deep ValueTrading at -2.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2012–2025
Loading P/E history...
P/E Ratio Analysis
As of June 21, 2026, Acadia Healthcare Company, Inc. (ACHC) trades at a price-to-earnings ratio of -2.0x, with a stock price of $24.87 and trailing twelve-month earnings per share of $-12.18.
The current P/E is 110% below its 5-year average of 20.7x. Over the past five years, ACHC's P/E has ranged from a low of 13.6x to a high of 28.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, ACHC trades at a 109% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, ACHC trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ACHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ACHC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ACHC P/E vs Peers
Hospitals and inpatient facilities peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $9B | 6.1 | 0.38 | +37% | |
| $2B | 14.0 | - | -29% | |
| $9B | 26.3 | 1.91 | +14% | |
| $84B | 13.2 | 0.63 | +29% | |
| $15B | 11.1 | 0.34Best | -53% | |
| $426M | 0.8Lowest | - | +197%Best | |
| $125B | 70.7 | - | -62% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ACHC Historical P/E Data (2012–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | - | $24.76 | $1.17 | 21.2x | -68% |
| FY2025 Q2 | Jun 30 2025 | $22.69 | $1.51 | 15.0x | -77% |
| FY2025 Q1 | Mar 31 2025 | $30.32 | $2.03 | 14.9x | -77% |
| FY2024 Q4 | - | $39.65 | $2.77 | 14.3x | -78% |
| FY2024 Q3 | Sep 30 2024 | $63.41 | $3.05 | 20.8x | -68% |
| FY2023 Q2 | Jun 30 2023 | $79.64 | $2.96 | 26.9x | -59% |
| FY2023 Q1 | Mar 31 2023 | $72.25 | $3.05 | 23.7x | -64% |
| FY2022 Q4 | Dec 31 2022 | $82.32 | $3.00 | 27.4x | -58% |
| FY2022 Q3 | Sep 30 2022 | $78.18 | $3.10 | 25.2x | -61% |
| FY2022 Q2 | - | $67.63 | $3.05 | 22.2x | -66% |
| FY2022 Q1 | - | $65.53 | $2.66 | 24.6x | -62% |
| FY2021 Q4 | Dec 31 2021 | $60.70 | $2.10 | 28.9x | -56% |
| FY2020 Q3 | Sep 30 2020 | $29.48 | $1.13 | 26.1x | -60% |
| FY2020 Q2 | - | $25.12 | $1.19 | 21.1x | -68% |
| FY2020 Q1 | - | $18.35 | $1.28 | 14.3x | -78% |
| FY2019 Q4 | - | $33.22 | $1.24 | 26.8x | -59% |
| FY2018 Q3 | Sep 30 2018 | $35.20 | $2.58 | 13.6x | -79% |
| FY2018 Q2 | Jun 30 2018 | $40.91 | $2.57 | 15.9x | -76% |
| FY2018 Q1 | Mar 31 2018 | $39.18 | $2.47 | 15.9x | -76% |
| FY2017 Q4 | Dec 31 2017 | $32.63 | $2.29 | 14.2x | -78% |
| FY2017 Q3 | Sep 30 2017 | $47.76 | $1.97 | 24.2x | -63% |
| FY2017 Q2 | Jun 30 2017 | $49.38 | $0.09 | 548.7x | +742% |
| FY2017 Q1 | Mar 31 2017 | $43.60 | $0.17 | 256.5x | +294% |
| FY2016 Q4 | Dec 31 2016 | $33.10 | $0.08 | 413.8x | +535% |
| FY2016 Q3 | Sep 30 2016 | $49.55 | $0.18 | 275.3x | +322% |
| FY2016 Q2 | - | $55.40 | $1.96 | 28.3x | -57% |
| FY2016 Q1 | - | $55.11 | $1.80 | 30.6x | -53% |
| FY2015 Q4 | - | $62.46 | $1.72 | 36.3x | -44% |
| FY2015 Q3 | Sep 30 2015 | $66.27 | $1.51 | 43.9x | -33% |
| FY2015 Q2 | - | $78.33 | $1.52 | 51.5x | -21% |
| FY2015 Q1 | - | $71.60 | $1.46 | 49.0x | -25% |
| FY2014 Q4 | Dec 31 2014 | $61.21 | $1.49 | 41.1x | -37% |
| FY2014 Q3 | - | $48.50 | $1.36 | 35.7x | -45% |
| FY2014 Q2 | Jun 30 2014 | $45.50 | $1.22 | 37.3x | -43% |
| FY2014 Q1 | Mar 31 2014 | $45.12 | $1.03 | 43.8x | -33% |
| FY2013 Q4 | - | $47.33 | $0.84 | 56.3x | -14% |
| FY2013 Q3 | Sep 30 2013 | $39.43 | $0.70 | 56.3x | -14% |
| FY2013 Q2 | Jun 30 2013 | $33.07 | $0.56 | 59.1x | -9% |
| FY2013 Q1 | Mar 31 2013 | $29.39 | $0.48 | 61.2x | -6% |
| FY2012 Q4 | Dec 31 2012 | $23.35 | $0.52 | 44.9x | -31% |
Average P/E for displayed period: 65.2x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ACHC — Frequently Asked Questions
Quick answers to the most common questions about buying ACHC stock.
What is ACHC's P/E ratio?
Acadia Healthcare Company, Inc. (ACHC) trailing twelve-month P/E ratio is -2.0x, based on TTM diluted EPS of $-12.18. The 5-year average P/E is 20.7x and the historical range spans 13.6x to 28.9x.
Is ACHC stock overvalued or undervalued?
ACHC trades at -2.0x P/E, below its 5-year average of 20.7x. At the 0th percentile of its historical range (13.6x–28.9x), the stock is priced at a discount to its own history.
Is ACHC stock expensive?
No, ACHC is not expensive on a historical basis. The current P/E of -2.0x is below the 5-year average of 20.7x and sits at the 0th percentile of its valuation range.
What is ACHC's historical P/E range?
Over the past 5 years, ACHC's P/E ratio has ranged from 13.6x to 28.9x, with a median of 21.2x and an average of 20.7x. The current P/E of -2.0x places the stock at the 0th percentile of this range. Full historical data spans 2012–2025.
How does ACHC's P/E compare to the S&P 500?
ACHC trades at -2.0x P/E versus the S&P 500 median of 24.4x. The 108% discount to the market suggests lower growth expectations or perceived higher risk.
How does ACHC's valuation compare to Healthcare peers?
Acadia Healthcare Company, Inc. P/E of -2.0x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ACHC's PEG ratio?
ACHC PEG ratio is N/A, based on a P/E of -2.0x and EPS growth of -537.4%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is ACHC's earnings yield?
ACHC earnings yield is N/A, the inverse of its -2.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.